Rudolf-Giesbert Alken

Dr. Rudolf-Giesbert Alken is a clinical pharmacologist with internal medicine background. He is an approved specialist for pharmacology and toxicology and has broad experience in drug research and development based on his life-long work in academia, Big Pharma and own SME ventures. Dr. Alken has a track record of successfully planning, carrying out, evaluating and supervising more than 200 clinical trials in phase I-IV. His expertise and good relations to a number of European Authorities and FDA cover the need of innovative generic companies and start-ups for consensus guided drug development assessment and consulting.  Dr. Alken has more than 15 years experiences as founder and leader of privately owned group companies, which started from scratch with clinical research as CRO. After handing over the core business, he is managing and developing the activities of the own drug development companies which are acting as contract organizations or as ventures.